|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07D 413/14 | (2006.01) |
| C07D 413/00 | (2006.01) | ||
| C07D 405/14 | (2006.01) | ||
| C07D 405/12 | (2006.01) | ||
| A61K 31/496 | (2006.01) | ||
| A61P 3/10 | (2006.01) |
| (11) | Number of the document | 4192831 |
| (13) | Kind of document | T |
| (96) | European patent application number | 21853586.2 |
| Date of filing the European patent application | 2021-08-06 | |
| (97) | Date of publication of the European application | 2023-06-14 |
| (45) | Date of publication and mention of the grant of the patent | 2025-10-22 |
| (46) | Date of publication of the claims translation | 2026-02-10 |
| (86) | Number | PCT/CN2021/111193 |
| Date | 2021-08-06 |
| (87) | Number | WO 2022/028572 |
| Date | 2022-02-10 |
| (30) | Number | Date | Country code |
| PCT/CN2020/107437 | 2020-08-06 | WO | |
| PCT/CN2021/073958 | 2021-01-27 | WO |
| (72) |
MENG, Qinghua , CN
LEI, Hui , CN
ZHANG, Haizhen , CN
LIN, Xichen , CN
JENNINGS, Andrew , US
|
| (73) |
Gasherbrum Bio, Inc. ,
611 Gateway Blvd. Suite 223, South San Francisco, California 94080,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Heterocikliniai GLP#1 agonistai |
| HETEROCYCLIC GLP-1 AGONISTS |